EUVIMEDEUVIMED entdecken
Kohortenstudie

Long‐Term Risk of Inflammatory Bowel Disease With Sarcopenia Status: A Large‐Scale Prospective Cohort Study

Qian Zhang, Peijun Gui, Si Liu, Shengtao Zhu, Shutian Zhang, Shanshan Wu iD

Geriatrics & Gerontology International · 2026-04 · 26 (4)

DOI: 10.1111/ggi.70475 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Geriatrics & Gerontology International, online erschienen am 03.04.2026. Verfasst von Qian Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Sarcopenia, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Beijing Nova Program, Beijing High-Level Innovation and Entrepreneurship Talent Support Program Young Backbone Talent Projects, Chronic Disease Management Research Project of National Health Commission Capacity Building and Continuing Education Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The relationship between sarcopenia and Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), remains poorly understood. We aimed to investigate the association between risk of incident IBD and sarcopenia from a large, long‐term prospective cohort.

Methods

Participants free of prevalent IBD diagnosis at baseline ( N = 436 378) were included. Baseline sarcopenia status (probable and confirmed sarcopenia) was assessed according to EWGSOP2 criteria. The outcome of interest was incident IBD, CD, UC. Cox proportional hazard model was used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs).

Results

Overall, 56 947 (13.0%) and 2520 (0.6%) participants were diagnosed with probable sarcopenia and confirmed sarcopenia at baseline, respectively. During a median of 13.3 years' follow‐up, 2592 incident IBD cases (1858 UC, 895 CD) were identified. After multivariable adjustment, 81% and 94% higher risk of IBD (HR = 1.81, 95% CI: 1.27–2.58) and UC (HR = 1.94, 95% CI: 1.30–2.89) were observed in confirmed sarcopenia than the normal group, whereas no risk of CD associated with confirmed sarcopenia (HR = 1.56, 95% CI: 0.80–3.03) was detected. Particularly, evidently higher IBD risk (HR = 2.25, 95% CI: 1.39–3.64) and UC (HR = 2.58, 95% CI: 1.52–4.39) were detected in severe sarcopenia. Meanwhile, individuals with probable sarcopenia were associated with 26%, 27%, and 32% higher risk of IBD (HR = 1.26, 95% CI: 1.14–1.40), UC (HR = 1.27, 95% CI: 1.12–1.44), and CD (HR = 1.32, 95% CI: 1.11–1.58) versus normal individuals.

Conclusions

Sarcopenic individuals had an increased risk of developing IBD. It is necessary to conduct targeted screening for sarcopenia in high‐risk populations, and interventions to improve physical capability should be encouraged, which in turn may reduce the risk of developing IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaInflammatory Bowel DiseasesHumansFemaleMaleProspective StudiesMiddle AgedRisk FactorsIncidenceAgedAdultProportional Hazards ModelsColitis, UlcerativeRisk Assessment

Stichwörter der Autor:innen

Crohn's diseasecohort studyinflammatory bowel diseasesarcopeniaulcerative colitis

Autor:innen und Institutionen

  • Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • State Key Laboratory of Digestive Health, Beijing, China.
  • National Clinical Research Center for Digestive Diseases, Beijing, China.
  • Department of Rehabilitation Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Shanshan Wu

Förderung

  • Beijing Nova Program
  • Beijing High-Level Innovation and Entrepreneurship Talent Support Program Young Backbone Talent Projects
  • Chronic Disease Management Research Project of National Health Commission Capacity Building and Continuing Education Center

Zitieren

APA

Zhang, Q., Gui, P., Liu, S., Zhu, S., Zhang, S., & Wu, S. (2026). Long‐Term Risk of Inflammatory Bowel Disease With Sarcopenia Status: A Large‐Scale Prospective Cohort Study. Geriatrics & Gerontology International, 26(4). https://doi.org/10.1111/ggi.70475

Vancouver

Zhang Q, Gui P, Liu S, Zhu S, Zhang S, Wu S. Long‐Term Risk of Inflammatory Bowel Disease With Sarcopenia Status: A Large‐Scale Prospective Cohort Study. Geriatrics & Gerontology International. 2026;26(4). doi:10.1111/ggi.70475

BibTeX
@article{Zhang2026,
  author = {Zhang, Qian and Gui, Peijun and Liu, Si and Zhu, Shengtao and Zhang, Shutian and Wu, Shanshan},
  title = {Long‐Term Risk of Inflammatory Bowel Disease With Sarcopenia Status: A Large‐Scale Prospective Cohort Study},
  journal = {Geriatrics & Gerontology International},
  year = {2026},
  volume = {26},
  number = {4},
  doi = {10.1111/ggi.70475}
}
Kostenlos starten →